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The purpose of this study was to investigate the relation between 
acoustic properties of the myocardium and magnitude of left 
ventricular hypertrophy in patients with hypertrophic cardiomy-
opathy. An on-line radio frequency analysis system was used to 
obtain quantitative operator-independent measurements of the 
integrated backscatter signal of the ventricular septum and pos-
terior free waD in 25 patients with hypertrophic cardiomyopathy 
and 25 normal age-matched control subjects. The integrated 
values of the radio frequency signal were normalized for the 
pericardial interface and expressed in percent. 
Tissue reflectivity was significantly increased in the hypertro-
phied ventricular septum, as weD as in the nonhypertrophied 
posterior free wall, in patients with hypertrophic cardiomyopathy 
(58 ± 15% and 37 ± 12%, respectively) compared with values in 
normal subjects (33 ± 10% and 18 ± 5%, respectively; p < 
0.001). Furthermore, measurements of reflectivity of the septum 
In patients with hypertrophic cardiomyopathy, conventional 
echocardiography often shows increased ultrasonic reflec-
tivity of the left ventricular wall (l,2). However, our under-
standing of myocardial reflectivity and the clinical applica-
tions of this ultrasonic feature are hampered by the high 
dependency of tissue reflectivity on gain settings and the 
electronics of the individual echocardiographic instruments 
(3). 
New methods were recently proposed (3) to obtain quan-
titative, operator-independent measurements of ultrasonic 
tissue reflectivity. In particular, on-line measurements of 
radio frequency ultrasound signals may permit objective and 
relatively simple assessment of the acoustic properties of the 
myocardium in humans (4-6). Therefore, in the present 
investigation we used an on-line radio frequency analysis 
system to obtain quantitative and operator-independent 
measurements of ultrasonic reflectivity of the left ventricular 
wall in patients with hypertrophic cardiomyopathy and in 
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or posterior free wall, or both, were beyond 2 SD of normal values 
in >90% of the patients and were also abnormal in each ofthe five 
study patients who had only mild and localized left ventricular 
hypertrophy. No correlation was identified between myocardial 
tissue reflectivity and left ventricular wall thickness in the patients 
with hypertrophic cardiomyopathy (correlation coefficient r = 
0.4; p = NS). 
These findings demonstrate that myocardial reflectivity is 
abnormal in most patients with hypertrophic cardiomyopathy and 
is largely independent of the magnitude of left ventricular hyper-
trophy. Moreover, quantitative analysis of ultrasonic reflectivity 
can differentiate patients with hypertrophic cardiomyopathy from 
normal subjects independently of clinical features and conven-
tional echocardiographic measurements. 
(J Am Coll CardioI1991;17:1085-90) 
normal control subjects. The purpose of this study was to 
investigate myocardial tissue reflectivity and to assess the 
relation between the acoustic properties of the myocardium 
and left ventricular hypertrophy in patients with hyper-
trophic cardiomyopathy. 
Methods 
Study patients. Twenty-five patients with hypertrophic 
cardiomyopathy constituted the present study group. In 
each patient the diagnosis of hypertrophic cardiomyopathy 
had been established by the echocardiographic demonstra-
tion of a nondilated and hypertrophied left ventricle in the 
absence of another cardiac or systemic disease that could 
produce left ventricular hypertrophy of the magnitude ob-
served (7). Patients ranged in age from 17 to 60 years (mean 
42); 18 (72%) were male. Of the 25 patients, 20 (80%) were 
asymptomatic or had only mild cardiac symptoms (New 
York Heart Association functional class I or II) and 5 (20%) 
had moderate to severe symptoms (functional class III or 
IV). Presence of left ventricular outflow obstruction under 
basal conditions was assessed from the M-mode echocardio-
gram on the basis of the magnitude and duration of systolic 
anterior motion of the mitral valve (8,9). Significant left 
ventricular outflow tract obstruction (gradient ~30 mm Hg) 
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was considered to be present in 6 (24%) of the patients and 
absent in the other 19 (76%). 
Control group. Twenty-five normal subjects without clin-
ical, electrocardiographic and echocardiographic evidence 
of cardiovascular disease and similar to the patients with 
hypertrophic cardiomyopathy with regard to age and gender 
constitute the control group. The normal subjects ranged in 
age from 19 to 60 years (mean 39); 18 (72%) were male. 
Echocardiography. Conventional echocardiographic stud-
ies were performed with a Hewlett-Packard 77020ACI 
phased-array sector scanner using a 2.5 or 3.5 MHz trans-
ducer. Two-dimensional images were obtained in the 
parasternal long-axis and short-axis views and apical two 
and four chamber views with use of standard transducer 
positions (10). Thickness of the anterior ventricular septum 
and posterior free wall, end-diastolic dimension of the left 
ventricular cavity and left atrial size were measured from the 
M-mode echocardiographic tracings, according to the crite-
ria of the American Society of Echocardiography (11). 
Ultrasonic tissue characterization. A block diagram of the 
data acquisition system is shown in Figure 1. An OTE 
Biomedica SIM 3000 two-dimensional mechanical sector 
scanner echocardiograph was used for spatial orientation of 
the ultrasound beam; quantitative analysis of ultrasonic 
reflectivity was performed in the regions of interest, that is, 
the ventricular septum and posterior left ventricular free 
wall. These regions were visualized from the parasternal 
long-axis view. The acquisition of the backscatter signal was 
performed at end-diastole because a systematic variation in 
backscatter amplitude occurs during the cardiac cycle (12). 
A 3.5 MHz frequency transducer (focal distance 7 cm, 
- 3 dB focal region 6 cm) was used. The transducer band-
width, measured at - 3 dB with respect to the 3.5 MHz 
central frequency, is 700 KHz. 
The "native" (raw) radio frequency signal was sampled 
before the processing chain of the two-dimensional instru-
ment (Fig. 2). The radio frequency signal undergoes pream-
plification, bypassing the receiving circuits of the ultrasound 
equipment. The analog signal is fed to an amplifier and the 
gain sweep of the amplifier (from 2 to 60 dB) is accomplished 
in 30 steps. Such operation allows the full utilization of the 
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Figure 1. Block diagram of the system used for radio 
frequency (RF) quantitative analysis. 2D-IB = two-
dimensional integrated backscatter. 
input dynamic range of the analog to digital converter. 
Sampling is performed by a flash converter with 8 bits of 
amplitude resolution at a rate of 40 MHz. The digitized signal 
from analog to digital converter is analyzed in real time by a 
hardware prototype developed in our electronics laboratory 
(13). The acquisition of the two-dimensional gate is visual-
ized on the two-dimensional image to ensure its proper 
positioning. 
For analysis of the myocardium, the gate width was kept 
at 3 JLS, which corresponds to 2.35 mm (for 64 points), given 
the velocity of ultrasound in biologic tissues of 1.57 mml JLS. 
This allowed sampling of the radio frequency signal in the 
middle layers of the myocardium, thus excluding epicardial 
and endocardial specular reflections. The acquisition gate 
was kept just behind the specular echo of the endocardium 
(left endocardium for the septum) to minimize the transmural 
Figure 2. Schematic representation of the echographic screen of the 
acquisition system. The light sector within the ventricular septum 
represents the acquisition gate. At the upper right, the correspond-
ing radio frequency signals are visualized and measurements are 
obtained from the strongest signal (dark point and corresponding 
value under the panel). IB = integrated backscatter. 
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variations in backscatter that are influenced by the position 
from which the signal is acquired within the wall. The 
representative value for the ventricular septum and posterior 
free wall was calculated as the average of three values. For 
evaluation of the pericardial echo, a 1.5 I1S gate length was 
used, which corresponds to 1.2 mm for 32 points. The 
acquisition gate was centered on the strongest pericardial 
reflections just behind the mitral leaflets. The representative 
value for the pericardial echo was calculated as the mean of 
three values. 
The hardware analysis involved the measurement of the 
integrated amplitude of the rectified radio frequency signal 
corresponding to the two-dimensional area selected from the 
echocardiographic image. 
More analytically, the two-dimensional integrated back-
scatter index (2D-IB) was calculated at a tissue area, that is, 
corresponding to a (n-m) segment in depth and a (r-I) 
segment in lateral displacement, as follows: 
where 
represents the operation over the depth of the interrogated 
tissue, S(Xj, Yi) is the sequence of the digitized backscatter 
echoes over the selected two-dimensional area and I· I means 
the absolute value. 
The system provides a simultaneous display of conven-
tional information together with tissue characterization var-
iables (the two-dimensional integrated backscatter alphanu-
meric index and the lateral displacement profile averaged 
over the selected depth). Alphanumeric two-dimensional 
integrated backscatter data values are transferred on line to 
a personal computer (model AT) for statistical analysis (13). 
Ultrasonic quantitative data analysis. Two different meth-
ods were used to obtain a quantitative assessment of the 
reflectivity of the ventricular septum and posterior free wall: 
l) percent of two-dimensional integrated backscatter ex-
pressed as a comparison with the pericardial interface, and 
2) compensated two-dimensional integrated backscatter af-
ter off-line compensation procedure. 
Percent of two-dimensional integrated backscatter. 
Two-dimensional integrated backscatter results for each 
heart structure, initially displayed in mV, were then ex-
pressed in percent values, assuming as 100% the pericardial 
interface from which the maximal echo intensity was con-
sistently recorded in the individual patient. The individual 
pericardial signal strength was used to normalize myocardial 
signals in each patient (6,14). 
Compensated two-dimensional integrated backscatter. 
In this study a compensation procedure was adopted to 
overcome problems due to the variable attenuation effects of 
the interposed tissue. The rationale for this approach has 
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been extensively discussed by Melton and Skorton (15). This 
procedure was performed off line by determining the correc-
tion term for each tissue layer that constitutes the interposed 
tissues (each layer was assumed to behave homogeneously 
with respect to frequency-dependent losses) and then by 
multiplying this correction term for the amplitude signal 
originating from the tissue target (radio frequency gated 
signal). The correction term was evaluated as follows: the 
thickness of each tissue layer was measured from two-
dimensional targeted time-motion tracings; each thickness 
value was multiplied by the average attenuation coefficient 
(0.13 for chest wall, 0.13 for myocardium, 0.032 for blood) 
over the operating frequency range; and finally the exponen-
tial amplification (that is, opposite to the attenuation law) 
that represents the correction factor was measured (16). 
Statistical analysis. Data are reported as mean values ± 
SD. Intergroup differences were tested for significance using 
the unpaired Student's t test. Relations between radio fre-
quency and two-dimensional echocardiographic measure-
ments are expressed in terms of linear regression analysis. A 
p value of <0.01 was considered statistically significant. 
Results 
Technical feasibility and conventional echocardiographic 
findings. Technically satisfactory conventional echocardio-
graphic images and radio frequency ultrasonic signals were 
obtained in each subject. Ventricular septal thickness was 
significantly increased in patients with hypertrophic cardio-
myopathy (20 ± 3 mm) compared with normal control 
subjects (9 ± I mm, p < 0.001) and posterior free wall 
thickness was similar in the two groups (9 ± I and 9 ± I mm, 
respectively). Left ventricular end-diastolic cavity dimen-
sion was significantly smaller in patients with hypertrophic 
cardiomyopathy (45 ± 6 mm) than in the control subjects (51 
± 4 mm; p < 0.01). 
Quantitative analysis of ultrasound backscatter. Two-
dimensional integrated backscatter percent and compen-
sated values, as well as primary backscatter values, of the 
ventricular segments analyzed in the patients with hyper-
trophic cardiomyopathy and in the normal control subjects 
are reported in Table I and Figure 3. Percent and compen-
sated values of both the ventricular septum and posterior left 
ventricular free wall were significantly higher in the patients 
with hypertrophic cardiomyopathy than in the normal con-
trol subjects (p < 0.001). In addition, percent and compen-
sated two-dimensional integrated backscatter values of the 
ventricular septum were higher than the corresponding val-
ues of the posterior free wall both in patients and in normal 
control subjects (p < 0.01). By definition, percent two-
dimensional integrated backscatter values of the pericardium 
were 100% in patients and in control subjects; compensated 
two-dimensional integrated backscatter values of the peri-
cardium were similar and not significantly different in pa-
tients and control subjects. 
Individual patient analysis showed that two-dimensional 
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Table 1. Two-Dimensional Integrated Backscatter (2D-IB) Values of the Left Ventricular Wall in Patients With Hypertrophic 
Cardiomyopathy and in Control Subjects 
Compensated 2D-1B Percent 2D-1B 
Pe VS PW VS PW 
Patients with hypertrophic 255.4 ± 74.0 154.0 ± 35.2*t 125.5 ± 32.0* 58.0 ± 15.2*t 37.1 ± 12.0* 
cardiomyopathy 
Control subjects 225.7 ± 45.2 81.8 ± ll.3t 58.1 ± 10.7 32.6 ± 9.7t 17.6 ± 4.5 
*p < 0.001 when compared with the value of the control group; tp < 0.01 when compared with the posterior wall value within the same patient group. 
Pe = pericardium; PW = posterior wall; VS = interventricular septum. 
integrated backscatter values for both the ventricular septum 
and the posterior free wall were >2 SD of normal values in 
the great majority of the patients. Percent and compensated 
values for the septum were abnormal in 15 (60%) and 24 
(96%) of the study patients, respectively; percent and com-
pensated values for the posterior free wall were abnormal in 
17 (68%) and 21 (84%) of the patients. Two-dimensional 
integrated backscatter values for the septum, posterior free 
wall, or both, were also abnormal in each of the five study 
patients who had only mild and localized left ventricular 
hypertrophy, as assessed with two-dimensional echocar-
diography (17,18). 
Two-dimensional integrated backscatter percent and 
compensated values for the ventricular septum and posterior 
free wall were compared in the 20 study patients with 
hypertrophic cardiomyopathy who were asymptomatic or 
had only mild symptoms and in the 5 study patients with 
moderate to severe symptoms. However, none of the ultra-
sound backscatter indexes showed a significant difference in 
these two patient subgroups. 
Relation between conventional echocardiographic measure-
ments and radio frequency values. In the patients with hy-
pertrophic cardiomyopathy, the relation was analyzed be-
tween two-dimensional integrated backscatter values of the 
hypertrophied ventricular septum and conventional echocar-
diographic measurements of septal thickness and left ven-
tricular end-diastolic cavity dimension. No correlation was 
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identified between percent or compensated two-dimensional 
integrated backscatter values of the septum and septal 
thickness (r = 0.4 and r = 0.2, respectively; p = NS) or left 
ventricular end-diastolic cavity dimension (r = 0.1; p = NS). 
Discussion 
Ultrasonic reflectivity of the septum and posterior left 
ventricular wall in hypertrophic cardiomyopathy. In the 
present study we used an on-line radio frequency analysis 
system to obtain quantitative and operator-independent 
measurements of the acoustic properties of the myocardium 
in a relatively large population of patients with hypertrophic 
cardiomyopathy. It has been previously shown (4-6) that 
this technique can provide reliable and quantitative measure-
ments of myocardial acoustic properties in humans. Ultra-
sonic reflectivity was significantly increased in our study 
patients compared with normal control subjects, both in the 
hypertrophied ventricular septum and the nonhypertrophied 
posterior left ventricular free wall; regression analysis failed 
to identify a correlation between abnormal tissue reflectivity 
and ventricular septal thickness. Individual patient analysis 
showed that measurements of ultrasonic reflectivity of both 
the septum and posterior free wall were beyond 2 SD of 
normal values in the great majority of our study patients with 
hypertrophic cardiomyopathy; the compensated backscatter 
values for the ventricular septum were abnormal in >90% of 
• = HeM 
[] = Controls 
p <0.001 
Posterior 
Wall 
Figure 3. Comparison of percent (left) and com-
pensated (right) integrated backscatter indexes in 
the ventricular septum and posterior free wall of 
25 patients with hypertrophic cardiomyopathy 
and 25 normal subjects. 2D-IB = two-dimen-
sional integrated backscatter index; HCM = hy-
pertrophic cardiomyopathy. 
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the patients and those for the posterior free wall were 
abnormal in >80%. 
It is significant that ultrasound reflectivity of the ventric-
ular septum, posterior free wall, or both, was also abnormal 
in each of the five study patients who had only mild and 
localized left ventricular hypertrophy, as assessed with 
two-dimensional echocardiography (17,18). 
The results of the present investigation demonstrate that 
ultrasonic myocardial reflectivity can be quantified in pa-
tients with hypertrophic cardiomyopathy and that the acous-
tic properties of the left ventricular wall are abnormal in 
most patients with this disease. In addition, our results show 
that abnormal tissue reflectivity is not closely related to the 
magnitude of left ventricular hypertrophy. This is a poten-
tially important observation because it suggests that the 
abnormal acoustic properties of the myocardium are an 
expression of the intrinsic myopathic process and that this 
process also involves nonhypertrophied segments of the 
ventricular wall. This latter conclusion is supported by 
previous observations (17,19-23) showing that characteristic 
histologic abnormalities of hypertrophic cardiomyopathy 
(such as cardiac muscle disorganization, increased myocar-
dial cell size and abnormal intramural coronary arteries), as 
well as regional functional alterations, are present in seg-
ments of the wall that are of normal thickness or only mildly 
hypertrophied. 
The results of the present investigation also show that 
quantitative analysis of myocardial ultrasonic reflectivity 
can differentiate patients with hypertrophic cardiomyopathy 
from normal subjects independently of all other clinical and 
conventional echocardiographic features. This aspect of the 
technique could have direct clinical applications. For exam-
ple, analysis of ultrasonic reflectivity could be helpful in the 
diagnosis of hypertrophic cardiomyopathy in patients with 
mild left ventricular hypertrophy in whom the echocardio-
graphic evidence of increased wall thickness might be incon-
clusive. 
Comparison with previous studies. Chandrasekaran et al. 
(24) previously reported a computerized texture analysis of 
conventional echocardiographic recordings in patients with 
hypertrophic cardiomyopathy or cardiac amyloidosis. As in 
the present investigation, these authors identified increased 
intensity of the ultrasound signal in the ventricular septum of 
their study patients with hypertrophic cardiomyopathy; 
however, the intensity of the signal in the posterior wall did 
not differ significantly between patients and normal control 
subjects. This discrepancy between their findings and the 
increased reflectivity of the posterior wall identified in our 
study patients may have several explanations. The system 
used in this previous investigation was based on an off-line 
analysis of gray levels of conventional two-dimensional 
echocardiographic images, a method that may alter the 
ultrasonic characteristics of the insonated tissue (3). Fur-
thermore, the study group comprised only eight patients 
with hypertrophic cardiomyopathy. Thus, differences in 
measurements may not have reached statistical significance 
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because of the small number of patients studied; indeed, the 
echo intensity of the posterior free wall was> 30% greater in 
these eight patients than in normal control subjects. 
Recently Masuyama et al. (25) measured the cardiac 
cycle-dependent variation in integrated backscatter in the 
ventricular septum and posterior free wall of patients with 
hypertrophic cardiomyopathy, as well as in patients with 
pressure overload hypertrophy. In their study the amplitude 
of cyclic backscatter variation in the ventricular septum was 
reduced in patients with hypertrophic cardiomyopathy, 
whereas backscatter variation in the posterior free wall did 
not differ from that of normal control subjects. The cyclic 
variation in backscatter is a relatively "dynamic" variable 
and is substantially different from the absolute and "static" 
index of integrated backscatter used in the present study. 
Furthermore, cyclic variation in backscatter has a nonlinear 
relation with wall motion and wall thickening (26,27), which 
are abnormal in the ventricular septum but normal in the 
posterior free wall of most patients with hypertrophic car-
diomyopathy. 
We could not find a relation between severity of the 
clinical presentation and extent of ultrasound tissue abnor-
malities in our study popUlation. However, the great major-
ity of our patients with hypertrophic cardiomyopathy were 
asymptomatic or only mildly symptomatic because the 
present study population mainly comprised outpatients (28). 
Thus, we cannot exclude a relation between clinical features 
and ultrasonic tissue properties in a population comprising a 
larger percentage of severely symptomatic patients. 
Tissue reflectivity of septum versus posterior free wall. In 
the present investigation ultrasonic reflectivity showed sig-
nificant differences in intensity of the signals from the 
ventricular septum and the posterior free wall in patients 
with hypertrophic cardiomyopathy and normal control sub-
jects. This finding is consistent with previous data we and 
other investigators (4,14) obtained in patients with cardiac 
disease and normal subjects. The reasons for this difference 
in reflectivity between the septum and the posterior free wall 
are unclear. However, because this feature is present in both 
patients and normal subjects, it probably reflects technical 
aspects of ultrasound imaging. For example, the focal region 
of the transducer is closer to the septum than to the posterior 
wall. In addition, both the septum and the blood in the left 
ventricular cavity cause attenuation and diffraction of the 
signal produced by the posterior wall (an effect only in part 
reduced by the use of compensated backscatter values) (4). 
Finally, muscle fiber orientation, which differs in the septum 
and posterior wall, is an important determinant of tissue 
reflectivity and may playa role in the different echo inten-
sities of these two structures (4). 
Clinical application. The technology we used to obtain 
quantitative measurements of myocardial ultrasonic reflec-
tivity is relatively simple and can be added to commercially 
available echocardiographic instruments. Therefore, once 
the relation between abnormal tissue reflectivity and cardiac 
disease is definitively clarified, this technique could become 
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an attractive additional tool in the routine ultrasound exam-
ination of the heart and could complement conventional 
echocardiographic measurements of cardiac dimensions and 
function with information on myocardial tissue characteris-
tics. 
Conclusions. The results of this investigation show that 
the ultrasonic properties of the left ventricular myocardium 
are abnormal in most patients with hypertrophic cardiomy-
opathy and are largely independent of the magnitude of left 
ventricular hypertrophy. Our findings also suggest that quan-
titative analysis of ultrasonic reflectivity may permit differ-
entiation of patients with hypertrophic cardiomyopathy from 
normal subjects independently of clinical features and con-
ventional echocardiographic measurements. 
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